INJ. ARACYT 500 MG

INJ. ARACYT 500 MG
Product Description

 FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
.BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
. NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
. INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHYLAXIS AND TREATMENT OF MENINGEAL LEUKEMIA.
. PRESERVATIVE FREE 
. AVAILABLE FOR INTRATHECAL USES
. HIGHER DOSE CYTARABINE IS MORE EFFECTIVE IN MYELOID MALIGNANCIES PARTICULARLY IN  HIGH RISK PATIENTS.

Read more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile

More Products from RMPL Pharma LLP (99)

  • INJ. ADRIADOX 50 MG

    Product INJ. ADRIADOX 50 MG

    USED SUCCESSFULLY TO PRODUCE REGRESSION IN DISSEMINATED NEOPLASTIC CONDITIONS AS-
    1. CARCINOMA OF THE CERVIX, TESTIS, BREAST , OVARY AND LUNG.2. ACUTE LYMPHATIC LEUKEMIA AND ACUTE MYELOID LEUKOMIA
    3. HODGKING'S AND NON HODGKINGS LYMPHOMA4. SOFT TISSUE AND OSTEOGESIC  SARCOMA.
  • INJ. CANZATAX 100 MG

    Product INJ. CANZATAX 100 MG

    WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA :-
    USE IN - BREAST CARCINOMA                
    CERVICAL CARCINOMA           
    LUNG CARCINOMA           ...
  • INJ. CANZATAX 260 MG

    Product INJ. CANZATAX 260 MG

    WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA 
    USE IN - BREAST CARCINOMA                CERVICAL CARCINOMA               
    LUNG CARCINOMA        ...
  • INJ. CANZATAX 300 MG

    Product INJ. CANZATAX 300 MG

    WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA 
    USE IN - BREAST CARCINOMA                CERVICAL CARCINOMA               
    LUNG CARCINOMA      &n...
  • INJ. ARACYT 100 MG

    Product INJ. ARACYT 100 MG

    . FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
    .BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
    . NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
    . INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHYLAXIS AND ...
  • INJ. ARACYT 1000 MG

    Product INJ. ARACYT 1000 MG

     FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
    .BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
    . NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
    . INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHY...
  • INJ. BLEOCARE 15 IU

    Product INJ. BLEOCARE 15 IU

    USE IN-- SQUAMOUS CELL CARCINOMA AFFECTING HEAD AND NECK.- HODGKIN'S AND NON- HODGKIN'S LYMPHOMA.
    - TESTICULAR CARCINOMA.
  • INJ. CANCYT 1 GM

    Product INJ. CANCYT 1 GM

    USED TO TREAT CANCER OF THE BLADDER, PANCREAS , OVARY AND BREAST, AND NON- SMALL CELL LUNG CANCER.
  • INJ. CANCYTE 200 MG

    Product INJ. CANCYTE 200 MG

    USED TO TREAT CANCER OF THE BLADDER, PANCREAS , OVARY AND BREAST, AND NON- SMALL CELL LUNG CANCER.
  • INJ. CANPLATIN 10 MG

    Product INJ. CANPLATIN 10 MG

    USED IN - - METASTATIC OVARIAN CANCER
    - ADVANCED BLADDER CANCER
    - METASTATIC TESTICULAR CANCER
  • INJ. CANPLATIN 50 MG

    Product INJ. CANPLATIN 50 MG

    USED IN - - METASTATIC OVARIAN CANCER
    - ADVANCED BLADDER CANCER
    - METASTATIC TESTICULAR CANCER
  • INJ. COSMEDAC 0.5 MG

    Product INJ. COSMEDAC 0.5 MG

    USE IN -- WILM'S TUMOUR
    - CHILDHOOD RHABDOMYOSARCOMA
    - EWING'S SARCOMA AND METASTATIC NONSEMINOMATOUS TESTICULAR CANCER
    - GESTATIONAL TROPHOBLASTIC NEOPLASIA. 
show all 99 other products

RMPL Pharma LLP resources (1)

  • RMPL PHARMA LLP.

    Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.